ComplianceOnline

Compliance Resources to Help you Stay Current

Get trained on regulations affecting your industry through online webinars, learn the best practices, and download quality standards, checklists and news articles. Listen to experts on best practices to streamline quality and compliance processes and meet the regulatory demands.
Loading....

Gramm-Leach-Bliley Act – Background, Key Reforms & Provisions

  • Industry: Banking and Financial Services

The Gramm–Leach–Bliley Act (GLB), also known as the Financial Services Modernization Act of 1999, was signed into law by President Bill Clinton and it repealed part of the Glass–Steagall Act of 1933. The Act opened up the market among banking, securities and insurance companies. It requires financial institutions – companies that offer consumers financial products or services like loans, financial or investment advice, or insurance – to explain their information-sharing practices to their customers and to safeguard sensitive data.

483 sent to Jilin Shulan Synthetic Pharmaceutical Co.

  • Industry: Drugs and Chemicals (Pharma)

Warning letter sent to Jilin Shulan Synthetic Pharmaceutical Co. regarding significant deviations from Current Good Manufacturing Practice (CGMP) for the manufacture of APIs.

Doing Right Things When Designing Medical Devices

  • Industry: Medical Devices

Dr. W. Edward Deming, the architect of Japan’s world dominance in quality, used to say “working hard won’t help if you are working on the wrong things.” While this may not be quite appealing to many medical device developers, the opposite paradigm seems to make sense, which is, “working hard won’t help unless we are working on the right things.” This paradigm is a good value statement for medical devices. Therefore, we will discuss what some right things that are often overlooked are.

 

Sunrise Medical Laboratories, Inc received warning letter in violation to 21 CFR Part 1271

  • Industry: Laboratory Compliance

On Feb 23 2011 Sunrise Medical Laboratories, Inc a clinical and anatomical pathology laboratory received warning letter from FDA in relation to violation of not providing adequate protections against the risks of communicable disease transmission through the use of the HCT/Ps for which the company performs testing for relevant communicable diseases. The agency has also determined that there are reasonable grounds to believe this violative HCT/Ps pose a danger to health. Hence the agency has issued an order to Order to Cease Manufacturing effective with immediate notice. This Order to Cease Manufacturing relates to conduct occurring on or after May 25, 2005, the effective date of the applicable regulations. FDA retains authority to pursue other actions and remedies.

The warning letter states “Because of your failure to provide adequate protections against the risks of communicable disease transmission, pursuant to 21 CFR 1271.440(a)(3), Sunrise Medical Laboratories must immediately cease all manufacturing of HCT/Ps until compliance with the regulations in 21 CFR 1271 has been achieved and you have been provided written authorization from FDA to resume operations. Under 21 CFR 1271.3(e) manufacture means, but is not limited to, any or all steps in the recovery, processing, storage, labeling, packaging, or distribution of any HCT/P, and the screening or testing of the HCT/P donor.

Additionally, this is to advise you that FDA will notify, by copy of this Order, the client reproductive facilities for whom you performed donor testing since January 2008.”

FDA’s inspection and record review noted significant noncompliance with the federal regulations including, but not limited to, the following:

A. Donor Testing

  1. Failure to test using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer’s instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or disease [21 CFR 1271.80(c)]
  2. The manufacturer’s instructions for the hepatitis B core (HBc) assay state the absorbance value for the substrate blank must be greater than or equal to ---(b)(4)--- and less than or equal to ---(b)(4)--. The instructions further state that these criteria must be met in order for a plate (test run) to be considered valid. For 76 assays performed between January 2008 and October 2010, the blank absorbance value was greater than -(b)(4)-. The assays were not considered invalid and the results were reported to clients despite being obtained from an invalid test run.
  3. The manufacturers of the test kits used for HIV-1/2, HBc, hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV), require the use of a multichannel aspirator-washer capable of dispensing and aspirating 300µL to 800µL of wash solution per microplate well. In addition, the manufacturer’s instructions caution that strict adherence to the specified wash procedure is critical to ensure optimum assay performance. The instructions provide very specific steps to follow for washing the microplates. However, your firm’s procedure involves using a hand-held irrigation bottle to wash the wells, then inverting the microplates over a laboratory waste container to discard the wash solution. This method has been standard practice at Sunrise Medical Laboratories since January 2008, and was observed by the investigator during the inspection and documented in an affidavit signed by Mr. Paul Doherty, Laboratory Manager, on November 18, 2010.
  4. The incubation and washing steps for the HBc, HBsAg, HCV, and HIV-1/2 assays are not always performed for the required time specified in the manufacturer’s instructions. During the inspection, on October 28, 2010, the investigator observed that incubation times for specific steps in the assays were not documented or verified.
  5. The manufacturer’s instructions for the HBc assay require re-testing of donor specimens with an absorbance reading of less than -(b)(4)-. On 6/17/10, the absorbance reading for donor ----(b)(6)--- was -0.034. The donor specimen was not re-tested and the result of testing of this HCT/P donor was reported as negative.

B.Records

Failure to maintain records concurrently with the performance of each step required in subpart D and subpart C of Part 1271. 21 CFR 1271.270(a) states that any requirement in Part 1271 that an action be documented involves the creation of a record, which is subject to the requirements of this section. In addition, this section requires that all records must be accurate, indelible, and legible and that the records must identify the person performing the work and the dates of the various entries, and must be as detailed as necessary to provide a complete history of the work performed and to relate the records to the particular HCT/P involved. For example:

  1. From January 2008 to October 2010, you did not document incubation temperatures and times; solution preparation and usage times; and stop solution addition times for HBc, HBsAg, HCV, syphilis, and HIV-1/2 assays.
  2. The identification of the individual performing HBc, HBsAg, HIV-1/2, and syphilis assays was not documented on 180 out of -(b)(4)- worksheets/plate reader printouts.
  3. Donor specimen numbers were not documented on 40 out of -(b)(4)- data sheets/plate reader printouts for HBc assays performed in 2008.
  4. The calculation of the average value of the negative controls was not documented for three HCV assays and four HBsAg assays performed in 2008 and 2009

FDA further says that the testing was not performed in accordance with manufacturer’s instructions. Specifically: improper washing of microplates; failure to monitor the time and temperature of each step performed in testing; failure to invalidate test runs which did not meet manufacturer’s acceptance criteria and misinterpretation of test results based on use of an incorrect cutoff value.

FDA instructs the company to inform its’ client reproductive facilities and FDA of each donor test result that was affected by non-compliance with the manufacturer’s instructions in order that the client can make an informed decision regarding the status of the donor and /or any affected HCT/Ps that may remain in their inventory.

Source:

For more details of this warning letter http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/TissueSafety/ucm244563.htm

Home Mortgage Disclosure Act

  • Industry: Banking and Financial Services

Purpose Served by the Act

The Home Mortgage Disclosure Act (HMDA), enacted by the U.S Congress in 1975 and implemented by the Federal Reserve Board's Regulation C, requires depository institutions and certain for-profit, non-depository institutions to collect, report to federal agencies, and disclose to the public data about:

CARB

  • Industry: EH&S, Green Compliance

The California Air Resources Board, also known as CARB or ARB, is the "clean air agency" in the government of California. Established in 1967 in the Mulford-Carrell Act, combining the Bureau of Air Sanitation and the Motor Vehicle Pollution Control Board, CARB is a department within the cabinet-level California Environmental Protection Agency. California is the only state that is permitted to have such a regulatory agency, since it is the only state that had one before the passage of the federal Clean Air Act. Other states are permitted to follow CARB standards, or use the federal ones, but not set their own.

Environmental Protection Agency and its Regulation

  • Industry: EH&S, Green Compliance

The U.S. Environmental Protection Agency (EPA or sometimes USEPA) is an agency of the federal government of the United States charged with protecting human health and the environment, by writing and enforcing regulations based on laws passed by Congress. The EPA was proposed by President Richard Nixon and began operation on December 3, 1970, after Nixon submitted a reorganization plan to Congress. It was ratified by committee hearings in the House and Senate. The agency is led by its Administrator, who is appointed by the President and approved by Congress. The current administrator is Lisa P. Jackson. The EPA is not a Cabinet department, but the administrator is normally given cabinet rank. The agency has approximately 18,000 full-time employees.

Environmental Protection Agency and its Regulation

  • Industry: EH&S, Green Compliance

The U.S. Environmental Protection Agency (EPA or sometimes USEPA) is an agency of the federal government of the United States charged with protecting human health and the environment, by writing and enforcing regulations based on laws passed by Congress. The EPA was proposed by President Richard Nixon and began operation on December 3, 1970, after Nixon submitted a reorganization plan to Congress. It was ratified by committee hearings in the House and Senate. The agency is led by its Administrator, who is appointed by the President and approved by Congress. The current administrator is Lisa P. Jackson. The EPA is not a Cabinet department, but the administrator is normally given cabinet rank. The agency has approximately 18,000 full-time employees.

Lacey Act 2008

  • Industry: EH&S, Green Compliance

The Lacey Act was first introduced by Iowa Congressman John Lacey in the spring of 1900. It was signed into law by President William McKinley on May 25, 1900. The original Act was directed more at the preservation of game and wild birds by making it a federal crime to poach game in one state with the purpose of selling the bounty in another. It was also concerned with the potential problems of the introduction of non-native, or exotic species of birds and animals into native ecosystems.

Lacey Act 2008

  • Industry: EH&S, Green Compliance

The Lacey Act was first introduced by Iowa Congressman John Lacey in the spring of 1900. It was signed into law by President William McKinley on May 25, 1900. The original Act was directed more at the preservation of game and wild birds by making it a federal crime to poach game in one state with the purpose of selling the bounty in another. It was also concerned with the potential problems of the introduction of non-native, or exotic species of birds and animals into native ecosystems.

Oil Pollution Act

  • Industry: EH&S, Green Compliance

The Oil Pollution Act caused a major restructuring of the oil industry. It created the need for oil spill prevention and response technology and equipment. In all, the OPA had nine titles. This article describes the penalties, prevention and removal provisions in the Oil Pollution Act.

Solvency II

  • Industry: Risk Management

Solvency II is a new, stronger EU-wide requirement on capital adequacy and risk management for insurers with the aim of increasing protection for policyholders. The strengthened regime should reduce the possibility of consumer loss or market disruption in insurance.

Solvency I was a minimum harmonization directive introduced in the early 1970s. It allowed for differences to emerge in the way that insurance regulation was applied across Europe leading to different regimes. It was also primarily focused on the prudential standards for insurers and did not include requirements for risk management and governance within firms.

ISO 9001:2008

  • Industry: Quality Management

The International Organization for Standardization (ISO) was established in 1947 and is currently an association of 159 member-countries. ISO employs a system of Technical Committees, Sub-committees and Working Groups to develop International Standards. Besides the National Standards Bodies, ISO permits other international organizations that develop standards to participate in its work, by accepting them as Liaison members. ISO works in accordance with an agreed set of rules of procedure, the ISO/IEC Directives, which also include requirements on the presentation of standards.

Standard Instructions for Filing Forms under Securities Act of 1933

  • Industry: Banking and Financial Services

Part 229 furnishes, amongst other things, standard instructions for filing forms under Securities Act of 1933. Part 229 is part of Chapter II that deals with the Securities & Exchange Commission. This chapter appears under Title 17 of the Electronic Code of Federal Regulations that deals with Commodity and Securities Exchanges. The following Table furnishes the requirements of the important items under Part 229:

Hazardous Materials Transportation Act (HMTA)

  • Industry: Trade and Logistics Compliance

The U.S Congress passed the Hazardous Materials Transportation Act (HMTA) in 1975 in response to extensive illegal dumping of hazardous material. Its stated purpose is "to provide adequate protection against the risks to life and property inherent in the transportation of hazardous material in commerce by improving the regulatory and enforcement authority of the Secretary of Transportation."

Industrial Relations Act 1979

  • Industry: Trade and Logistics Compliance

The Industrial Relations Act 1979 seeks to consolidate and amend the law relating to the prevention and resolution of conflict in respect of industrial matters, the mutual rights and duties of employers and employees, the rights and duties of organizations of employers and employees, and for related purposes. It is comprised of seven parts. The important parts of the legislation and what they cover are explained in the following Table:

The National Organic Program (NOP)

  • Industry: Food Safety Compliance

The Organic Foods Production Act (OFPA) of 1990 required the U.S. Department of Agriculture (USDA) to develop national standards for organically produced agricultural products. This requirement led to the inception of the National Organic Program (NOP). The NOP is a marketing program housed within the USDA Agricultural Marketing Service. NOP regulates the standards for any farm, wild crop harvesting, or handling operation that wants to sell an agricultural product as organically produced.

PCI Data Security Standard

  • Industry: IT control and PCI compliance

The PCI Data Security Standard (PCI DSS) is a payment card security process which helps to prevent credit card frauds through increased controls aimed at detection and reaction to incidents involving security issues. The standards provide an actionable framework for execution of a robust security system for the safety of the payment card industry.

RoHS Regulation (Directive 2002/95/EC) - Overview of Regulatory Requirements

  • Industry: OSHA Compliance

RoHS stands for "Restriction of Hazardous Substances". The RoHS Regulation (Directive 2002/95/EC) came into force in July 2006. This is a European Union (EU) directive that restricts the use of six hazardous substances in the manufacture of new electrical and electronic equipment. It is closely linked with the Waste Electrical and Electronic Equipment Directive (WEEE) 2002/96/EC which defines collection, recycling and recovery targets for electrical goods.

Adjudication Division Rules

  • Industry: GSA Compliance

 Adjudication Division Rules (the ‘Rules’) govern the activities of, and the practice and procedure in, the adjudication division of the Immigration and Refugee Board. The rules are part of a Canadian legislation, called the Immigration and Refugee Protection Act (the ‘Act’). 


Best Sellers
You Recently Viewed
    Loading